VXRT News and Press, Vaxart Inc. From 07/14/20

IMV (NASDAQ: IMV ) +162%   rallies on COVID-19 vaccine progress. More news on: IMV Inc., VolitionRx Limited, INmune Bio, Inc., Stocks on the move, , Read more ...

With participation based on interest received from RA Capital Management and Invus, Vaxart ( VXRT +59.3% ) raised  ~$90M in gross proceeds through its At-the-Market (ATM) facility. More news on: Vaxart, Inc., , Healthcare stocks news, Stocks on the move, Read more ...

SOUTH SAN FRANCISCO, Calif., July 13, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT), a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by injection, today announced that it has raised gross proceeds of approximately $90 millio...

Gainers: Equillium (NASDAQ: EQ )  +220% . More news on: Equillium, Inc., electroCore, Inc., WiMi Hologram Cloud Inc., Stocks on the move, , Read more ...

Shares of Vaxart (NASDAQ: VXRT) were skyrocketing 26.4% higher as of 11:22 a.m. EDT on Monday. The huge jump came after investment bank B. Riley FBR initiated coverage on the stock with a buy rating and a price target of $22. This price target represented a 176% premium over Vaxart's closing...

July 13, 2020 FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – July 13, 2020 – Coronavirus cases continue to rise in the US this month as regulations lift, causing overambitious governors in several states to backpedal on previous cl...

Before the pandemic, most healthcare investors had probably never heard of the vaccine biotech Vaxart (NASDAQ: VXRT) . At the end of 2019, Vaxart's market cap was a minuscule $16.9 million, a far cry from the nearly $700 million it has reached today. Because of the pandemic, however, Vaxart's...

The following medical companies have filed for mixed shelf offerings: More news on: Ardelyx, Inc., Vaxart, Inc., Alpine Immune Sciences, Inc., Healthcare stocks news, , Read more ...

Let's talk about two companies developing COVID-19 vaccines that are much different from the ones we're generally used to. These two aren't going the traditional route of injecting a weakened version of the pathogen into the body. They have new ways of addressing the problem. You've probably he...

Vaxart (NASDAQ: VXRT) , a biotech company focused on the development of oral vaccines, had an underwhelming performance in the stock market in 2019 with its shares dropping by more than 80%. But largely thanks to the company's efforts to develop a vaccine for COVID-19, the stock has soared by...